Education
About Us
Working with TipRanks
Follow Us
Elaine Heron Insider Profile
4 Followers
Elaine Heron, Director at BioMarin Pharmaceutical, holds 53.69K shares in Palvella Therapeutics (Ticker: PVLA), holds 96.57K shares in Vaxart (Ticker: VXRT), holds 97.72K shares in BioMarin Pharmaceutical (Ticker: BMRN). Most recently, Elaine Heron Bought ― shares of Palvella Therapeutics on Mar 02, 2026 for an estimated value of $300.00K.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+13.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Elaine Heron holds in companies
Most Profitable Insider Trade
The most profitable trade made by Elaine Heron
Elaine Heron's Trading History
BioMarin Pharmaceutical
Jun 04, 2024
Director
Uninformative Buy
55.46K
$5.48M
Vaxart
Nov 21, 2025
Director
Informative Buy
15.77K
$65.18K
Palvella Therapeutics
Mar 02, 2026
Director
Informative Buy
300.00K
$6.49M
List of latest transactions for each holding click on a transaction to see Elaine Heron's performance on stock
You May Also Like
Elaine Heron insider profile FAQ
What is the percentage of profitable transactions made by Elaine Heron?
The percentage of profitable transactions made by Elaine Heron is 60%.
What is the average return per transaction made by Elaine Heron?
The average return per transaction made by Elaine Heron is 13.10%.
What stocks does Elaine Heron hold?
Elaine Heron holds: BMRN, VXRT, PVLA stocks.
What was Elaine Heron’s latest transaction?
Elaine Heron latest transaction was an Informative Buy of $300.00K.
What was Elaine Heron's most profitable transaction?
Elaine Heron’s most profitable transaction was an Informative Buy of VXRT stock on November 21, 2025. The return on the trade was 73.30%.
What is Elaine Heron's role in BioMarin Pharmaceutical?
Elaine Heron's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.